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Purpose or Objective  
A means of reducing PSQA measurements for VMAT is 
currently a popular topic of discussion due to the resource 
burden it generates and the increased use of VMAT. The 
reluctance to reduce or replace PSQA may be partly due 
to the difficulty in identifying the cause/s of plan failures. 
Plans may fail due to a large number of potential factors 
caused by the TPS, linac or measurement device. The goal 
of this study was to uncover the reason/s why a selection 
of VMAT plans have failed. 
Material and Methods  
Five ‘bad’ plans yielding low (failing) gamma  pass-rates 
and high average gamma-values were s elected for 
analysis. Two ‘good’ plans yielding high gamma pass-rates 
and low average gamma values were also used for 
comparison. The plans were measured with SNC ArcCHECK 
(1220 Model) cylindrical detector diode array and analysed 
with gamma analysis in SNC Patient software. The 
institutional tolerance was ≥95% of the points must pass a 
gamma analysis with 3% and 2mm gamma criteria, with a 
10% threshold and with the Van Dyk option (global gamma 
analysis) turned on. The control points for each plan were 
broken up into separate static fields applying the small arc 
approximation used by TPSs to calculate dynamic arc 
beams. The fields were then calculated in the Eclipse TPS 
(AAA) and delivered to the ArcCHECK. The individual static 
field measurements were compared to the individual 
calculations using an in-house Python script. Dose-
differences were tracked field-by-field for each diode and 
categorised into 5 components according to the location 
of the diode in the irradiation geometry: In-field Entrance 
side, in-field exit side, penumbra entrance side, 
penumbra exit side and out-of-field. Results presented 
highlighted the contribution each component had to the 
overall dose difference. 
Results  
A composite measurement of individual control point 
fields compared with the conventional PSQA measurement 
showed minimal difference indicating that the main 
reason for PSQA fail was not due to the dynamic delivery. 
The out-of-field component appeared to have  the 
greatest impact on the overall pass-rate as highlighted in 
the figures below where an example of both a ‘good’ and 
‘bad’ plan are shown. It has been widely reported that 
diodes over–respond to low energy photons. A proposed 
solution to the problem was to use the latest version of 
the SNC Patient software (v6.7) which provides out-of-
beam corrections for this over-response. The impact of 
applying the out-of-field correction resulted in all 
previously failed plans passing the gamma criteria stated 
earlier. 
 
 
 
 
 
Conclusion  
Deconstructing failed PSQA measurements proved useful 
in identifying the main source of error and lead to proving 
that these were false-positive results due to detector 
limitations. The manufacturers have released a new 
version of software with the ability to reduce this 
limitation. The results of this study indicate this 
correction should be adopted. 
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Purpose or Objective  
kV radiotherapy continues to be an important modality in 
modern radiotherapy, but has received less research 
attention in recent years. There remains a challenge to 
accurately calculate and verify treatment dose 
distributions for clinical sites with significant surface 
irregularity or where the treated region contains 
inhomogeneities, e.g. nose and ear. The accuracy of 
current treatment calculations has a significant level of 
uncertainty [1, 2]. The objective of this work was to 
characterise two novel detectors, micro-silica bead TLDs 
and Gafchromic EBT3 film, for in-vivo measurements for 
kV treatments, and to compare measured doses with 
conventional treatment calculations. 
[1. Currie (2007) Australas Phys Eng Sci Med, 2. Chow 
(2012) Rep Pract Oncol Radiother.] 
Material and Methods  
Micro-silica bead TLDs (1 mm diam.) and Gafchromic EBT3 
film were calibrated against an NPL traceably calibrated 
ionisation chamber using an Xstrahl D3300 kV radiotherapy 
treatment unit. Energy response was evaluated over 70 to 
250 kV and compared to 6 MV, useable dose range was 
evaluated from 0 to 25 Gy, and uncertainty budgets 
determined. Silica beads were cleaned, annealed, and TL 
response individually calibrated. EBT3 film was used with 
triple-channel dosimetry via FilmQAPro® with procedures 
to reduce uncertainties. Commissioning tests were 
undertaken in standard conditions using Solid Water blocks 
and in simulated clinical treatment condition using a 
custom made ‘wax face with nose’ phantom. Pilot in vivo 
measurements were made for a consecutive series of eight 
clinical patient treatments, including cheek, ear, nose and 
rib sites, over 70 to 250 kV, and 4 to 18 Gy. Results for the 
two dosimetry systems were compared to conventional 
treatment planning calculations. 
Results  
Energy response varied by 460% for beads and 9% for film, 
from 70 kV to 6 MV, necessitating energy-specific 
calibration. Both dosimeters were useable up to 25 Gy. 
Standard uncertainty was 3.1% for beads, 2.1% for film. 
The figure shows typical film and bead positions within the 
lead cut-out of a kV treatment to the cheek. The table 
provides calculated and measured doses. Average 
deviation over 6 patients was -1.3% for beads, -0.9% for 
film. 3 patients had larger deviations; See table note 1: 
tumour sitting over the maxillary sinus may reduce dose. 
Note 2: beads placed along surface of tumour into ear, 
most distal bead received dose -17.5% from prescription, 
doctor made compensation. Note 3: Increased uncertainty 
due to curved surface, film required offset to corner as 
patient sensitive to contact. Note 4: Uncertainty 
increased due to large respiratory motion at treatment 
site. 
 
 
 
 
Conclusion  
Both micro-silica bead TLDs and EBT3 film were 
characterised as suitable for in vivo dosimetry in kV 
radiotherapy, providing assurance of delivered doses. Film 
is simpler to prepare, use and read. A line of beads allows 
conformation to irregular anatomy across the field. A 
clinical service is now available to verify dose delivery in 
complex  clinical  sites. 
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Purpose or Objective  
To characterize protons and ion beams to determine the 
mean ionization potential (I-value) of water to be used in 
Monte Carlo simulations with the Geant4 Monte Carlo 
toolkit at energies of interest in particle therapy. The 
magnitude of this parameter has a strong influence on the 
Bragg Peak spatial position which, to our knowledge, is a 
key factor for treatment planning. 
Material and Methods  
The energy deposition distributions with respect to depth 
in water were obtained using an experimental setup 
(figure 1) which consists in a water tank, which thickness 
can be varied with micrometric accuracy, and two 
ionization chambers (ICs), the first one placed 
downstream the beam exit window (IC1) and the second 
one just behind the water tank (IC2). The mean energy 
deposition relative to the mean energy deposition at the 
entrance as function of depth in water were obtained from 
the ratio between the ionization produced in IC2 with 
respect to that of IC1. These measurements were carried 
out for various ion species covering a range in water 
between 5 and 28 cm, approximately. The absolute depth 
in water was determined with an estimated uncertainty of 
0.2 mm. 
Our Geant4 simulations were done using an ideal geometry 
(figure 2) composed by a water tank containing cylindrical 
scoring volumes, with a radius of 28 mm (actual radius of 
the ICs) and a thickness of 50 microns (similar to the water 
equivalent thickness of the ICs), to tally the energy 
deposition. 
For the simulation of each particular beam the energy 
spread was adjusted by fitting the width of the 
experimental distal fall-off prior determining the optimum 
I-value by matching our calculated 82% distal depth with 
the experimental one. 
